Pharma industry’s fears: Free trade may bring inferior drugs from India

PPMA former chief says Pakistan’s medicines are of far better quality than India.


Kazim Alam October 06, 2012

KARACHI:


The bigwigs of the pharmaceutical industry are upset with the government. On the one hand, they claim, it has wreaked havoc on local drug manufacturers by passing the 18th Amendment, which turned the health sector from a federal subject into a provincial one.

On the other hand, they say, the government is about to destroy their businesses by lifting trade restrictions that have so far protected local players from their Indian counterparts.


“Out of India’s roughly 25,000 drug manufacturers, only a 100 or so are foreign accredited, with state-of-the-art facilities and standardised, quality products. They produce high-value drugs and export to developed countries only,” said Dr Kaiser Waheed, former chairman of the Pakistan Pharmaceutical Manufacturers Association (PPMA) while speaking to The Express Tribune.

“It’ll be silly to think that those 100 companies will export to Pakistan once Pakistan-India trade barriers are lifted. What Pakistan will be importing in the name of free trade with India is substandard and spurious drugs produced by the overwhelming majority of the pharmaceutical industry of India that is, by and large, unregulated,” he added.

Explaining his argument, Waheed stated that unlike Pakistan’s pharmaceutical industry, which is regulated by a national body called the Drug Regulatory Authority, India’s drug manufacturers operate without a central regulatory framework. “Each state in the Indian federation has its own rules, regulations and regulatory body. Sometimes rules are adhered to, sometimes not. There is no standardisation and no central authority to streamline the pharmaceutical sector.”

While shortages of everyday medicines in Pakistan’s drugstores are not unusual, the fact remains that the country’s pharmaceutical exports have been rising steadily. Although the World Trade Organisation (WTO) says Pakistan’s exports of pharmaceutical products were over $150 million in 2011, the PPMA says they are now touching the mark of $200 million a year.

So how exactly has Pakistan managed to increase its pharmaceutical exports by an annual rate of 7% for the past five years, even though it sometimes fails to meet the local demand?

“Pakistan does not export pharmaceutical products to regulated markets. We export to countries whose pharmaceutical sectors are either semi-regulated or unregulated,” says Waheed.

His bold acknowledgement of the underlying factor that is driving Pakistan’s pharmaceutical exports upwards is backed by revealing statistics. The biggest export destination for Pakistani drugs is Afghanistan, which has a considerably weak regulatory framework. With a share of almost one-fifth in Pakistan’s total exports of pharmaceutical goods to the world, Afghanistan received Pakistani drugs worth $29.1 million in 2011.

It is noteworthy that Pakistan’s pharmaceutical exports to Afghanistan have grown by 30% per annum for the last five years. Sri Lanka, the Philippines, Vietnam and Sudan are other major export destinations for Pakistan-made drugs.

It is mainly the fear of substandard medicines flooding Pakistani drugstores that the pharmaceutical industry is opposed to unconditional easing of trade restrictions with India, says Waheed.

Currently, a large proportion of pharmaceutical products that Pakistan imports every year comes from developed countries with heavily regulated pharmaceutical sectors. Switzerland, Denmark, Germany, Belgium and France are the top five exporters of pharmaceutical goods to Pakistan, according to the WTO.

Drugs coming out of the unregulated pharmaceutical sector of India will replace existing medicines of far better quality if Pakistan eases the trade policy without providing the local industry with a level playing field, says Waheed.

Published in The Express Tribune, October 7th, 2012. 

COMMENTS (28)

Sexton Blake | 8 years ago | Reply

Dear Raj, You are correct in thinking I use Ayurvedic Medicine. The point I am making is that I am not aware of people dying as a result of using them. The so called polluted medicines are not shipped to America, but one suspects that the studies carried out so far, which have been quite vague, have been conducted by certain groups who do wish to see them marketed in the USA. I am certain that if anybody had died those vested interests would have let us know. Further, this contrasts quite strongly with Big Pharma. who are experiencing a high death rate, and an example of this is Viox. So far about 60,000 people who used Viox are dead, and we just do not know how many have been severely damaged. The bottom line is that we do not have enough data, and people like me who have been damaged by prescription medicine have to try alternative medicine in order to return to health, and this is just not good enough. I could write a 10,000 word dissertation on this problem, and which prescription drugs have had to be withdrawn from the market place. What I have found is that Allopathic doctors (Western Medicine) are not really sure what will happen when they subscribe many medicines, and if one reacts badly to a drug they blithely say: "you had better stop taking it". Until they get it right I will stick with Indian Ayurvedic products. I am of quite an age now, have not been damaged, and to the best of my knowledge am not suffering from arsenic poisoning.

Raj - USA | 8 years ago | Reply

@Sexton Blake:

You are talking probably about Indian Ayurvedic medicines. Ayurvedic medicines contain heavy metals. In USA it is not sold as medicine but as health supplement to by pass the FDA rules. Ayurveda is a different Ancient science made mainly from herbs, but also has metals. Many claim it works. I do not have any personal experience.

VIEW MORE COMMENTS
Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ

E-Publications

Most Read